-
1
Efficacy and safety of ustekinumab in the treatment of moderate to severe plaque psoriasis in Singapore
Published 2023-07-01Subjects: Get full text
Article -
2
Comparison of the Effectiveness of Vedolizumab and Ustekinumab in Patients with Ulcerative Colitis: A Real-World Retrospective Study
Published 2024-09-01Subjects: Get full text
Article -
3
Combination therapy of Crohn's disease with an interleukin 12/23 inhibitor and a targeted immunosuppressant: Clinical cases
Published 2025-01-01Subjects: Get full text
Article -
4
RESULTS OF USTEKINUMAB TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS IN THE RUSSIAN FEDERATION ACCORDING TO THE DATA OF PSUMMIT 1 AND PSUMMIT 2
Published 2015-04-01Subjects: Get full text
Article -
5
New Possibilities for the Treatment of Crohn’s Disease
Published 2019-12-01Subjects: Get full text
Article -
6
Renal Dysfunction in a Patient With Crohn's Disease During Ustekinumab Treatment: A Case Report and Review of the Literature
Published 2024-01-01Subjects: Get full text
Article -
7
Immunopathogenetic mechanisms of action of ustekinumab, a new drug for the treatment of psoriatic arthritis and psoriasis
Published 2015-06-01Subjects: Get full text
Article -
8
CLINICAL EXPERIENCE WITH USTEKINUMAB IN THE TREATMENT OF EARLY PSORIATIC ARTHRITIS USING TREAT-TO-TARGET STRATEGY
Published 2015-09-01Subjects: Get full text
Article -
9
Successful Treatment of Ustekinumab-Associated Lichenoid Drug Eruption with Upadacitinib: A Case Report
Published 2025-04-01Subjects: Get full text
Article -
10
Comparative Evaluation of the Treatment Efficacy and Safety of TNFα and IL12/23 Inhibitors in Children With Psoriasis
Published 2019-02-01Subjects: Get full text
Article -
11
Inflammatory linear verrucous epidermal nevus successfully treated with ustekinumab
Published 2025-04-01Subjects: Get full text
Article -
12
Short-Term Effectiveness of Ustekinumab in Crohn’s Disease: Results from a Real-World Retrospective Multicenter Study in China
Published 2025-05-01Subjects: “…Ustekinumab…”
Get full text
Article -
13
Difficulties in choosing a biologic disease-modifying anti-rheumatic drug for the treatment of psoriasis and psoriatic arthritis
Published 2019-03-01Subjects: Get full text
Article -
14
Biosimilar SB17 versus reference ustekinumab in moderate to severe plaque psoriasis after switching: phase 3 study results up to week 52
Published 2024-12-01Subjects: Get full text
Article -
15
The Effects of the Biological Agents Infliximab, Vedolizumab, and Ustekinumab on Intestinal Anastomosis: An Experimental Study in Rats
Published 2025-04-01Subjects: Get full text
Article -
16
Clinical Predictive Factors of Response to Biologics in IBD
Published 2022-03-01Subjects: Get full text
Article -
17
Research Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of Surgery
Published 2023-11-01Subjects: Get full text
Article -
18
Early Ustekinumab Use Improves Clinical Outcomes in Biologic-Naive Crohn’s Disease Patients: A Retrospective Multicenter Cohort Study in Taiwan
Published 2025-02-01Subjects: Get full text
Article -
19
Superior persistence of ustekinumab compared to anti-TNF in vedolizumab-experienced inflammatory bowel diseases patients: a real-world cohort study
Published 2024-12-01Subjects: Get full text
Article -
20
Bullous Pyoderma Gangrenosum Associated with Antiphospholipid Syndrome: A Case Report and Literature Review
Published 2024-07-01Subjects: Get full text
Article